Intuitive Surgical (ISRG) to Release Earnings on Tuesday

Intuitive Surgical (NASDAQ:ISRG - Get Free Report) will likely be releasing its Q2 2025 earnings data after the market closes on Tuesday, July 22nd. Analysts expect Intuitive Surgical to post earnings of $1.92 per share and revenue of $2.35 billion for the quarter.

Intuitive Surgical (NASDAQ:ISRG - Get Free Report) last announced its quarterly earnings results on Tuesday, April 22nd. The medical equipment provider reported $1.81 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $1.71 by $0.10. Intuitive Surgical had a return on equity of 14.43% and a net margin of 28.41%. The business had revenue of $2.25 billion for the quarter, compared to the consensus estimate of $2.19 billion. During the same period last year, the business posted $1.50 EPS. On average, analysts expect Intuitive Surgical to post $6 EPS for the current fiscal year and $8 EPS for the next fiscal year.

Intuitive Surgical Trading Down 0.9%

Shares of NASDAQ:ISRG traded down $4.46 on Wednesday, reaching $507.77. The company had a trading volume of 360,012 shares, compared to its average volume of 1,679,159. Intuitive Surgical has a 52-week low of $413.82 and a 52-week high of $616.00. The firm's 50 day simple moving average is $537.18 and its 200-day simple moving average is $536.37. The firm has a market capitalization of $182.00 billion, a PE ratio of 74.49, a PEG ratio of 5.48 and a beta of 1.64.

Analysts Set New Price Targets

Several research analysts recently weighed in on ISRG shares. Piper Sandler dropped their target price on Intuitive Surgical from $670.00 to $575.00 and set an "overweight" rating on the stock in a research note on Wednesday, April 23rd. Barclays dropped their target price on Intuitive Surgical from $684.00 to $635.00 and set an "overweight" rating on the stock in a research note on Thursday, April 24th. Royal Bank Of Canada lowered their price target on Intuitive Surgical from $630.00 to $605.00 and set an "outperform" rating for the company in a research report on Wednesday, April 23rd. Erste Group Bank raised Intuitive Surgical from a "hold" rating to a "buy" rating in a research report on Thursday, June 5th. Finally, Citigroup reaffirmed a "buy" rating and set a $650.00 price target (up previously from $590.00) on shares of Intuitive Surgical in a research report on Thursday, May 22nd. One equities research analyst has rated the stock with a sell rating, four have given a hold rating and fifteen have given a buy rating to the stock. Based on data from MarketBeat.com, the company has an average rating of "Moderate Buy" and an average target price of $592.86.

Insider Transactions at Intuitive Surgical

In related news, SVP Mark Brosius sold 216 shares of the stock in a transaction that occurred on Friday, June 6th. The stock was sold at an average price of $563.11, for a total value of $121,631.76. Following the completion of the sale, the senior vice president owned 907 shares of the company's stock, valued at approximately $510,740.77. This trade represents a 19.23% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. Also, Director Jami K. Nachtsheim sold 2,400 shares of the stock in a transaction that occurred on Thursday, May 1st. The shares were sold at an average price of $520.00, for a total value of $1,248,000.00. Following the completion of the sale, the director directly owned 6,371 shares of the company's stock, valued at approximately $3,312,920. This represents a 27.36% decrease in their position. The disclosure for this sale can be found here. Insiders sold 4,998 shares of company stock worth $2,611,577 over the last three months. 0.70% of the stock is owned by insiders.

Institutional Investors Weigh In On Intuitive Surgical

An institutional investor recently raised its position in Intuitive Surgical stock. Brighton Jones LLC increased its holdings in Intuitive Surgical, Inc. (NASDAQ:ISRG - Free Report) by 24.9% in the 4th quarter, according to its most recent disclosure with the SEC. The firm owned 3,672 shares of the medical equipment provider's stock after acquiring an additional 731 shares during the period. Brighton Jones LLC's holdings in Intuitive Surgical were worth $1,916,000 at the end of the most recent quarter. Institutional investors and hedge funds own 83.64% of the company's stock.

Intuitive Surgical Company Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.